Improving immune function after radiation damage
Modulation of signaling from damage-associated molecular patterns to improve radiation-induced thymic dysfunction
This study is looking at ways to help your immune system bounce back better after radiation treatment by figuring out how certain cells in your body can help T cells recover in the thymus, which is important for fighting off infections.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11088873 on NIH RePORTER |
What this research studies
This research investigates how to enhance the recovery of T cells in the thymus after radiation exposure, which can severely impair immune function. The team is exploring two key pathways that promote thymic regeneration, focusing on specific factors produced by immune and endothelial cells. By understanding how different types of cell death influence these regenerative processes, the researchers aim to identify new therapies that could help patients recover their immune system more effectively after radiation treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced radiation exposure and are facing challenges with their immune system recovery.
Not a fit: Patients who have not been exposed to radiation or do not have thymic dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for patients suffering from radiation-induced immune dysfunction.
How similar studies have performed: Previous research has shown promise in similar approaches to enhance immune recovery, indicating potential for success in this area.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Dudakov, Jarrod — Fred Hutchinson Cancer Center
- Study coordinator: Dudakov, Jarrod
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.